Federal Health Agency Revokes Contract with Fetal Tissue Supplier

Health and Human Services plans to review all research involving human fetal tissue.

Written bySukanya Charuchandra
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: © ISTOCK, FRENTUSHA

The US Department of Health and Human Services has canceled a contract between the Food and Drug Administration and a supplier of human fetal tissue, Advanced Bioscience Resources, according to an announcement on September 24. The company would have received $15,900 for human fetal tissue that would be used to make a laboratory mouse’s immune system more closely resemble a human’s, according to BuzzFeed News.

The move was preceded by a letter addressed to Food and Drug Administration (FDA) Commissioner Scott Gottlieb a week ago in which 85 House Republicans said they were troubled with the then-active contract. The letter also claimed that the supplier had broken federal and state laws in the course of its sale of human fetal tissue.

Health and Human Services (HHS) says in the statement it “was not sufficiently assured that the contract included the appropriate protections applicable to fetal tissue ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies